Long-term follow-up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials, a comprehensive assessment of prognostic factors

• Published in: American Journal of Hematology
• Main Authors: Allsup, D., Craig, Z., Cairns, D., Howard, D., Hockaday, A., Bloor, A., Soe, Z., Pepper, C., Gattei, V., Zucchetto, A., Robbe, P., Clifford, R., Schuh, A., Munir, T., Rawstron, A., Hillmen, P.
• Other Authors: Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK. Clinical Trials Research Unit, University of Leeds, Leeds, UK. The Christie NHS Foundation Trust, Manchester, UK. St James Institute of Oncology, Leeds, UK. Clinical and Experimental Medicine, Brighton and Sussex Medical School, Brighton, UK. Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italy. Laboratory for Transcriptome Technology, RIKEN Centre for Integrative Medical Sciences, Yokohama, Japan. Department of Haematology, University Hospital Limerick, Limerick, Ireland. Department of Oncology, University of Oxford, Oxford, UK. Haematological Malignancy Diagnostic Service, St James Hospital, Leeds, UK. Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
• Format: Other/Unknown Material
• Language: English
• Published: 2022
• Subjects: Arctic
• Online Access: http://hdl.handle.net/10541/625070; https://doi.org/10.1002/ajh.26483